A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

Two small life sciences firms—Genevant and Arbutus—accused Moderna of violating their patents for the lipid nanoparticle technology used in Moderna's COVID-19 vaccine. Without this technology, Moderna ...

Creative Biolabs With the enabling platforms and technologies at its disposal, Creative Biolabs is poised to address critical challenges in ...